Moditen (Fluphenazine Hydrochloride)

Fluphenazine hydrochloride, the active ingredient in Moditen, is a phenothiazine typical antipsychotic presented as an oral dosage form for systemic use. It is employed in the management of schizophrenia and acute psychotic episodes, helping to control delusions, hallucinations, and severe agitation in adult patients.

GNH USA supplies Moditen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance, regulatory compliance, and reliable logistics across multiple regions. Our distribution network ensures timely delivery and supports pharmacovigilance initiatives.

Fluphenazine hydrochloride is a phenothiazine antipsychotic that acts on dopaminergic pathways to manage psychotic disorders.

- Schizophrenia: reduces core psychotic symptoms and helps maintain long‑term stability. - Acute psychotic episodes: provides rapid control of agitation, hallucinations and delusions. - Maintenance therapy for schizophrenia: assists in preventing relapse of psychotic symptoms.

Fluphenazine hydrochloride may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Sedation: feeling unusually drowsy or sleepy. - Extrapyramidal symptoms: tremor, rigidity, or involuntary movements. - Dry mouth: reduced salivation leading to discomfort. - Constipation: slowed gastrointestinal motility.

Serious or Rare Side Effects: - Neuroleptic malignant syndrome: life‑threatening fever, muscle rigidity, and autonomic instability. - Tardive dyskinesia: persistent involuntary facial or limb movements. - Agranulocytosis: severe reduction in white blood cells increasing infection risk.

Before initiating therapy, clinicians should consider several safety measures. - Monitor extrapyramidal symptoms: observe for tremor, rigidity, or involuntary movements. - Assess cardiovascular status: watch for orthostatic hypotension or arrhythmias. - Avoid abrupt discontinuation: taper under medical supervision to prevent rebound psychosis. - Use caution in elderly patients with dementia: increased risk of mortality. - Check for hypersensitivity: discontinue if rash, swelling, or anaphylaxis occurs. - Store at ambient temperature: keep in original container, protect from moisture and light.

Fluphenazine hydrochloride can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - CYP2D6 inhibitors (e.g., paroxetine, fluoxetine): may increase plasma concentrations. - Anticholinergic agents: can mask extrapyramidal side effects. - QT‑prolonging drugs (e.g., quinidine, sotalol): raise risk of cardiac arrhythmias.

Moderate Interactions (Monitor Closely): - Central nervous system depressants (alcohol, benzodiazepines): additive sedation. - Lithium: potential for increased neurotoxicity. - Antihypertensives: may enhance hypotensive effects.